• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞外囊泡 miR-210 作为口腔鳞状细胞癌患者诊断和生存预测的潜在生物标志物。

Extracellular vesicles miR-210 as a potential biomarker for diagnosis and survival prediction of oral squamous cell carcinoma patients.

机构信息

Department of Neuroscience, Psychology, Drug Research and Child Health - NEUROFARBA - Section, University of Florence, Florence, Italy.

Department of Otorhinolaryngology, Careggi University Hospital, Florence, Italy.

出版信息

J Oral Pathol Med. 2022 Apr;51(4):350-357. doi: 10.1111/jop.13263. Epub 2021 Dec 1.

DOI:10.1111/jop.13263
PMID:34800057
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9300091/
Abstract

BACKGROUND

The identification of early diagnostic and prognostic biomarkers in oral squamous cell carcinoma (OSCC) is an unmet clinical need. We hypothesized that extracellular vesicles miR-210 expression (EV-miR-210) could be a potential biomarker for OSCC diagnosis and follow-up.

METHODS

The expression of EV-miR-210 was measured in the plasma of OSCC patients (n = 30) and compared to that of controls (n = 14).

RESULTS

The median EV-miR-210 expression was significantly higher in OSCC patients compared to controls who had often, undetectable levels (p < 0.0001). We performed receiver operating characteristic (ROC) analysis for discriminating OSCC cases from controls. EV-miR-210 yielded an area under the curve (AUC) of 0.9513 with sensitivity 92.3% and specificity 86.6%. Kaplan-Meier curves indicated that high EV-miR-210 expression was associated with worse 3 years' survival (p < 0.05). Cox regression hazard model indicated that high EV-miR-210, G2, and G3 grading and pathological nodal status (pN)>1 were independent predictors of worse survival in OSCC patients.

CONCLUSION

These preliminary data suggest that EV-mir-210 may be a novel diagnostic and prognostic biomarker in OSCC.

摘要

背景

在口腔鳞状细胞癌(OSCC)中,鉴定早期诊断和预后生物标志物是一个未满足的临床需求。我们假设细胞外囊泡 miR-210 表达(EV-miR-210)可能是 OSCC 诊断和随访的潜在生物标志物。

方法

测量了 OSCC 患者(n=30)和对照组(n=14)血浆中 EV-miR-210 的表达。

结果

与对照组相比,OSCC 患者的 EV-miR-210 表达中位数明显更高,对照组通常检测不到 EV-miR-210 表达(p<0.0001)。我们进行了区分 OSCC 病例和对照组的接收者操作特征(ROC)分析。EV-miR-210 的曲线下面积(AUC)为 0.9513,具有 92.3%的敏感性和 86.6%的特异性。Kaplan-Meier 曲线表明,高 EV-miR-210 表达与较差的 3 年生存率相关(p<0.05)。Cox 回归风险模型表明,高 EV-miR-210、G2 和 G3 分级以及病理性淋巴结状态(pN>1)是 OSCC 患者生存较差的独立预测因子。

结论

这些初步数据表明,EV-mir-210 可能是 OSCC 的一种新型诊断和预后生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a980/9300091/ea6fe2a91009/JOP-51-350-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a980/9300091/46f11233cc32/JOP-51-350-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a980/9300091/29e3d1894101/JOP-51-350-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a980/9300091/ea6fe2a91009/JOP-51-350-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a980/9300091/46f11233cc32/JOP-51-350-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a980/9300091/29e3d1894101/JOP-51-350-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a980/9300091/ea6fe2a91009/JOP-51-350-g001.jpg

相似文献

1
Extracellular vesicles miR-210 as a potential biomarker for diagnosis and survival prediction of oral squamous cell carcinoma patients.细胞外囊泡 miR-210 作为口腔鳞状细胞癌患者诊断和生存预测的潜在生物标志物。
J Oral Pathol Med. 2022 Apr;51(4):350-357. doi: 10.1111/jop.13263. Epub 2021 Dec 1.
2
Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.血清微小RNA-483-5p:口腔鳞状细胞癌患者一种新型的诊断和预后生物标志物。
Tumour Biol. 2016 Jan;37(1):447-53. doi: 10.1007/s13277-015-3514-z. Epub 2015 Jul 30.
3
Salivary extracellular vesicle-associated miRNAs as potential biomarkers in oral squamous cell carcinoma.唾液细胞外囊泡相关 microRNA 作为口腔鳞状细胞癌潜在的生物标志物。
BMC Cancer. 2018 Apr 18;18(1):439. doi: 10.1186/s12885-018-4364-z.
4
MiR-92b as a marker for TPF induced chemotherapy response prediction and prognosis evaluation in with advanced oral squamous cell carcinoma patients.miR-92b 作为晚期口腔鳞状细胞癌患者 TPF 诱导化疗反应预测和预后评估的标志物。
Cell Mol Biol (Noisy-le-grand). 2020 Jun 5;66(3):24-31.
5
Diagnostic and prognostic value of serum miR-99a expression in oral squamous cell carcinoma.血清 miR-99a 表达在口腔鳞状细胞癌中的诊断和预后价值。
Cancer Biomark. 2018;23(3):333-339. doi: 10.3233/CBM-181265.
6
"Salivary LINC00657 and miRNA-106a as diagnostic biomarkers for oral squamous cell carcinoma, an observational diagnostic study".“唾液 LINC00657 和 miRNA-106a 作为口腔鳞状细胞癌的诊断生物标志物,一项观察性诊断研究”。
BMC Oral Health. 2023 Dec 12;23(1):994. doi: 10.1186/s12903-023-03726-0.
7
miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.miR-654-5p靶向GRAP,通过Ras/MAPK信号通路促进口腔鳞状细胞癌的增殖、转移和化疗耐药性。
DNA Cell Biol. 2018 Apr;37(4):381-388. doi: 10.1089/dna.2017.4095. Epub 2018 Jan 24.
8
Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma.全基因组唾液 microRNA 研究鉴定 miR-423-5p 作为口腔鳞状细胞癌有前途的诊断和预后生物标志物。
Theranostics. 2021 Jan 1;11(6):2987-2999. doi: 10.7150/thno.45157. eCollection 2021.
9
Down-regulation of miR-200c associates with poor prognosis of oral squamous cell carcinoma.miR-200c 的下调与口腔鳞状细胞癌的不良预后相关。
Int J Clin Oncol. 2020 Jun;25(6):1072-1078. doi: 10.1007/s10147-020-01649-2. Epub 2020 Mar 11.
10
A Five-mRNA Expression Signature to Predict Survival in Oral Squamous Cell Carcinoma by Integrated Bioinformatic Analyses.基于综合生物信息学分析的五信使 RNA 表达特征预测口腔鳞状细胞癌患者的生存情况。
Genet Test Mol Biomarkers. 2021 Aug;25(8):517-527. doi: 10.1089/gtmb.2021.0066.

引用本文的文献

1
Exosomal MicroRNAs as novel diagnostic biomarkers in head and neck cancer: a systematic evaluation and meta-analysis.外泌体微小RNA作为头颈癌新型诊断生物标志物的系统评价与Meta分析
Eur Arch Otorhinolaryngol. 2025 Aug 31. doi: 10.1007/s00405-025-09643-y.
2
Metabolic biomarker in oral squamous cell carcinoma - a comprehensive review.口腔鳞状细胞癌中的代谢生物标志物——综述
GMS Interdiscip Plast Reconstr Surg DGPW. 2025 Apr 16;14:Doc01. doi: 10.3205/iprs000190. eCollection 2025.
3
Extracellular vesicles in the pathogenesis and future diagnostics of oral squamous cell carcinoma.

本文引用的文献

1
OSCC Exosomes Regulate miR-210-3p Targeting EFNA3 to Promote Oral Cancer Angiogenesis through the PI3K/AKT Pathway.口腔鳞状细胞癌外泌体通过 PI3K/AKT 通路调节 miR-210-3p 靶向 EFNA3 促进口腔癌血管生成。
Biomed Res Int. 2020 Jul 8;2020:2125656. doi: 10.1155/2020/2125656. eCollection 2020.
2
Exosomal microRNA-210 is a potentially non-invasive biomarker for the diagnosis and prognosis of glioma.外泌体微小RNA-210是一种用于胶质瘤诊断和预后的潜在非侵入性生物标志物。
Oncol Lett. 2020 Mar;19(3):1967-1974. doi: 10.3892/ol.2020.11249. Epub 2020 Jan 7.
3
Extracellular Vesicles in Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders: A Systematic Review.
细胞外囊泡在口腔鳞状细胞癌发病机制及未来诊断中的作用
Future Sci OA. 2025 Dec;11(1):2461940. doi: 10.1080/20565623.2025.2461940. Epub 2025 Feb 7.
4
MicroRNA expression as a prognostic biomarker of tongue squamous cell carcinoma (TSCC): a systematic review and meta-analysis.miRNA 表达作为舌鳞状细胞癌 (TSCC) 的预后生物标志物:系统评价和荟萃分析。
BMC Oral Health. 2024 Mar 31;24(1):406. doi: 10.1186/s12903-024-04182-0.
5
Exosome-based engineering strategies for the diagnosis and treatment of oral and maxillofacial diseases.基于外泌体的口腔颌面疾病诊断和治疗的工程策略。
J Nanobiotechnology. 2023 Dec 21;21(1):501. doi: 10.1186/s12951-023-02277-4.
6
Extracellular vesicles in oral squamous cell carcinoma: current progress and future prospect.口腔鳞状细胞癌中的细胞外囊泡:当前进展与未来展望
Front Bioeng Biotechnol. 2023 May 26;11:1149662. doi: 10.3389/fbioe.2023.1149662. eCollection 2023.
7
Extracellular Vesicles as Biomarkers in Head and Neck Squamous Cell Carcinoma: From Diagnosis to Disease-Free Survival.细胞外囊泡作为头颈部鳞状细胞癌的生物标志物:从诊断到无病生存期
Cancers (Basel). 2023 Mar 17;15(6):1826. doi: 10.3390/cancers15061826.
8
Liquid Biopsy for Oral Cancer Diagnosis: Recent Advances and Challenges.用于口腔癌诊断的液体活检:最新进展与挑战
J Pers Med. 2023 Feb 8;13(2):303. doi: 10.3390/jpm13020303.
9
The clinical implications of circulating microRNAs as potential biomarkers in screening oral squamous cell carcinoma.循环微小RNA作为口腔鳞状细胞癌筛查潜在生物标志物的临床意义
Front Oncol. 2022 Nov 17;12:965357. doi: 10.3389/fonc.2022.965357. eCollection 2022.
10
Plasma Extracellular Vesicles-Derived miR-99a-5p: A Potential Biomarker to Predict Early Head and Neck Squamous Cell Carcinoma.血浆细胞外囊泡衍生的 miR-99a-5p:预测头颈部鳞状细胞癌早期的潜在生物标志物。
Pathol Oncol Res. 2022 Oct 18;28:1610699. doi: 10.3389/pore.2022.1610699. eCollection 2022.
口腔鳞状细胞癌和口腔潜在恶性疾病中外泌体的系统评价。
Int J Mol Sci. 2020 Feb 11;21(4):1197. doi: 10.3390/ijms21041197.
4
miR-TV: an interactive microRNA Target Viewer for microRNA and target gene expression interrogation for human cancer studies.miR-TV:一个交互式 miRNA 靶标查看器,用于人类癌症研究中 miRNA 和靶基因表达的检测。
Database (Oxford). 2020 Jan 1;2020. doi: 10.1093/database/baz148.
5
miRNAs in liquid biopsy for oral squamous cell carcinoma diagnosis: Systematic review and meta-analysis.液体活检中 miRNA 用于口腔鳞状细胞癌诊断的系统评价和荟萃分析。
Oral Oncol. 2019 Dec;99:104465. doi: 10.1016/j.oraloncology.2019.104465. Epub 2019 Nov 20.
6
Salivary exosomal miR-24-3p serves as a potential detective biomarker for oral squamous cell carcinoma screening.唾液外泌体 miR-24-3p 可作为口腔鳞状细胞癌筛查的潜在检测生物标志物。
Biomed Pharmacother. 2020 Jan;121:109553. doi: 10.1016/j.biopha.2019.109553. Epub 2019 Nov 5.
7
Time patterns of recurrence and second primary tumors in a large cohort of patients treated for oral cavity cancer.口腔癌患者大样本的复发和第二原发肿瘤的时间模式。
Cancer Med. 2019 Sep;8(12):5810-5819. doi: 10.1002/cam4.2124. Epub 2019 Aug 10.
8
Increased salivary microvesicles are associated with the prognosis of patients with oral squamous cell carcinoma.唾液微囊泡增多与口腔鳞状细胞癌患者的预后相关。
J Cell Mol Med. 2019 Jun;23(6):4054-4062. doi: 10.1111/jcmm.14291. Epub 2019 Mar 25.
9
Survival outcomes after treatment of cancer of the oral cavity (1985-2015).口腔癌治疗后的生存结果(1985-2015 年)。
Oral Oncol. 2019 Mar;90:115-121. doi: 10.1016/j.oraloncology.2019.02.001. Epub 2019 Feb 15.
10
Downregulation of RGMA by HIF-1A/miR-210-3p axis promotes cell proliferation in oral squamous cell carcinoma.缺氧诱导因子 1A/miR-210-3p 轴下调 RGMA 促进口腔鳞状细胞癌细胞增殖。
Biomed Pharmacother. 2019 Apr;112:108608. doi: 10.1016/j.biopha.2019.108608. Epub 2019 Feb 21.